Takeda UK Ltd
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- PANTOPRAZOLE TAKEDA gastro-resistant tablet 20 mg
- PANTOPRAZOLE TAKEDA gastro-resistant tablet 40 mg
- PROTIUM powder for solution for injection 40 mg
- A07 - Antidiarreicos, antiinfecciosos y antiinflamatorios intestinales
- MEZAVANT prolonged-release tablet 1 200 mg
- A10 - Antidiabéticos
- ACTOS tablet 15 mg
- ACTOS tablet 30 mg
- ACTOS tablet 45 mg
- COMPETACT film-coated tablet 850 mg+15 mg
- VIPDOMET film-coated tablet 1 000 mg+12.5 mg
- VIPIDIA film-coated tablet 12.5 mg
- VIPIDIA film-coated tablet 25 mg
- VIPIDIA film-coated tablet 6.25 mg
- A12 - Suplementos minerales
- CALCICHEW chewable tablet 500 mg Ca
- CALCICHEW D3 chewable tablet 1 250 mg (500 mg Ca)+200 IU
- CALCICHEW D3 chewable tablet 1 g Ca+800 IU
- CALCICHEW D3 FORTE chewable tablet 1 250 mg (500 mg) +400 IU
- CALCICHEW FORTE chewable tablet 1 g Ca
- A16 - Otros productos para el tracto alimentario y metabolismo
- ELAPRASE concentrate for solution for infusion 6 mg/3 ml
- B01 - Agentes antitrombóticos
- CEPROTIN powder and solvent for solution for injection 1 000 IU+10 ml
- CEPROTIN powder and solvent for solution for injection 500 IU+5 ml
- B02 - Antihemorrágicos
- ADYNOVI powder and solvent for solution for injection 1 000 IU+2 ml
- ADYNOVI powder and solvent for solution for injection 1 000 IU+5 ml
- ADYNOVI powder and solvent for solution for injection 2 000 IU+5 ml
- ADYNOVI powder and solvent for solution for injection 250 IU+2 ml
- ADYNOVI powder and solvent for solution for injection 250 IU+5 ml
- ADYNOVI powder and solvent for solution for injection 500 IU+2 ml
- ADYNOVI powder and solvent for solution for injection 500 IU+5 ml
- FEIBA powder and solvent for solution for infusion 1 000 IU
- FEIBA powder and solvent for solution for infusion 2500 IU
- FEIBA powder and solvent for solution for infusion 500 IU
- OBIZUR powder and solvent for solution for injection 500 IU+1 ml
- TACHOSIL MEDICATED SPONGE cutaneous sponge 5.5 mg/cm²+2 IU/cm²
- B06 - Otros agentes hematológicos
- CINRYZE powder and solvent for solution for injection 500 IU
- FIRAZYR PREFILLED SYRINGE solution for injection 30 mg/3 ml
- C02 - Antihipertensivos
- INTUNIV prolonged-release tablet 1 mg
- INTUNIV prolonged-release tablet 2 mg
- INTUNIV prolonged-release tablet 3 mg
- INTUNIV prolonged-release tablet 4 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- AMIAS tablet 16 mg
- AMIAS tablet 2 mg
- AMIAS tablet 32 mg
- AMIAS tablet 4 mg
- AMIAS tablet 8 mg
- EDARBI tablet 20 mg
- EDARBI tablet 40 mg
- EDARBI tablet 80 mg
- D06 - Antibióticos y quimioterápicos para uso dermatológico
- CONDYLINE cutaneous solution 0.5%
- H05 - Homeostasis del calcio
- NATPAR powder and solvent for solution for injection 100 µg/dose
- NATPAR powder and solvent for solution for injection 25 µg/dose
- NATPAR powder and solvent for solution for injection 50 µg/dose
- NATPAR powder and solvent for solution for injection 75 µg/dose
- J05 - Antivirales de uso sistémico
- LIVTENCITY film-coated tablet 200 mg
- J06 - Sueros inmunes e inmunoglobulinas
- CUVITRU solution for injection 200 mg/ml
- GAMMAGARD S/D powder and solvent for solution for infusion 10 g
- GAMMAGARD S/D powder and solvent for solution for infusion 5 g
- HYQVIA solution for infusion 10 g/100 ml
- HYQVIA solution for infusion 2.5 g/25 ml
- HYQVIA solution for infusion 20 g/200 ml
- HYQVIA solution for infusion 30 g/300 ml
- HYQVIA solution for infusion 5 g/50 ml
- KIOVIG solution for infusion 1 g/10 ml
- KIOVIG solution for infusion 10 g/100 ml
- KIOVIG solution for infusion 2.5 g/25 ml
- KIOVIG solution for infusion 20 g/200 ml
- KIOVIG solution for infusion 30 g/300 ml
- KIOVIG solution for infusion 5 g/50 ml
- L01 - Antineoplásicos
- ADCETRIS powder for solution for infusion 50 mg
- ALUNBRIG film-coated tablet 180 mg
- ALUNBRIG film-coated tablet 30 mg
- ALUNBRIG film-coated tablet 90 mg
- FRUZAQLA capsule, hard 1 mg
- FRUZAQLA capsule, hard 5 mg
- NINLARO capsule, hard 2.3 mg
- NINLARO capsule, hard 3 mg
- NINLARO capsule, hard 4 mg
- L02 - Terapia endocrina
- PROSTAP 3 DCS PREFILLED SYRINGE powder and solvent for solution for injection 11.25 mg+1 ml
- PROSTAP SR DCS PREFILLED SYRINGE powder and solvent for solution for injection 3.75 mg+1 ml
- L03 - Inmunoestimulantes
- MEPACT powder for suspension for injection 4 mg
- L04 - Inmunosupresores
- ALOFISEL suspension for injection 5 000 000 cells/ml
- ENTYVIO powder for solution for infusion 300 mg
- ENTYVIO PREFILLED PEN solution for injection 108 mg/0.68 ml
- ENTYVIO PREFILLED SYRINGE solution for injection 108 mg/0.68 ml
- N02 - Analgésicos
- INSTANYL nasal spray, solution 100 µg/dose
- INSTANYL nasal spray, solution 200 µg/dose
- INSTANYL nasal spray, solution 50 µg/dose
- MATRIFEN transdermal patch 100 µg/h
- MATRIFEN transdermal patch 12 µg/h
- MATRIFEN transdermal patch 25 µg/h
- MATRIFEN transdermal patch 50 µg/h
- MATRIFEN transdermal patch 75 µg/h
- N06 - Psicoanalépticos
- ELVANSE ADULT capsule, hard 30 mg
- ELVANSE ADULT capsule, hard 50 mg
- ELVANSE ADULT capsule, hard 70 mg
- ELVANSE capsule, hard 20 mg
- ELVANSE capsule, hard 30 mg
- ELVANSE capsule, hard 40 mg
- ELVANSE capsule, hard 50 mg
- ELVANSE capsule, hard 60 mg
- ELVANSE capsule, hard 70 mg
- EQUASYM prolonged-release capsule, hard 10 mg
- EQUASYM prolonged-release capsule, hard 20 mg
- EQUASYM prolonged-release capsule, hard 30 mg
- V03 - Todos los demás preparados terapéuticos
- FOSRENOL chewable tablet 1 000 mg
- FOSRENOL chewable tablet 500 mg
- FOSRENOL chewable tablet 750 mg
- FOSRENOL oral powder 1 000 mg
- FOSRENOL oral powder 750 mg